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1.  Introduction  
Bile acids (BA) are the major organic solutes of bile. They are amphiphilic molecules 
facilitating the intestinal absorption of fat-soluble compounds such as lipophilic vitamins and 
dietary lipids. Under normal physiological conditions, BA are actively taken up from portal 
blood into the hepatocytes primarily by sodium taurocholate cotransporting polypeptide 
[NTCP (human) or Ntcp (rat); SLC10A1/Slc10a1 gene] in a sodium-dependent manner. In 
addition, sodium-independent uptake by hepatic isoforms of the organic anion transporting 
polypeptide (OATP/Oatp; SLCO/Slco gene family) also plays a role. Subsequently, BA are 
conjugated in the liver with glycine and taurine (at the C24 carboxylic acid moiety) and may 
also be metabolized by different liver enzymes such as cytochrome P450s, glucuronosyl- and 
sulfotransferases. They finally undergo efflux into the bile canaliculi by the bile salt export 
pump (BSEP/Bsep, an ATP binding cassette (ABC) transporter; ABCB11/Abcb11 gene) 
(Kullak-ublick et al. 2004). Multidrug resistance-associated protein-2 (MRP2/Mrp2; 
ABCC2/Abcc2 gene) is another canalicular ABC transporter that mediates the canalicular 
efflux of divalent BA such as the sulfated glycine or taurine conjugates. MRP3/Mrp3 
(ABCC3/Abcc3) and MRP4 (ABCC4), localized at the basolateral side of the hepatocytes, are 
responsible for the efflux of the BA back into the sinusoidal blood (Alrefai and Gill 2007).  
BSEP is the transport protein primarily responsible for the elimination of monovalent BA at 
the canalicular membrane. Its inhibition is implicated in the pathogenesis of estrogen-induced 
intrahepatic cholestasis of pregnancy. Genetic defects in BSEP can lead to progressive 
familial intrahepatic cholestasis type 2 (Dawson et al. 2009). Bsep (or BSEP) function can 
also be affected by endo- (e.g. estradiol-17β-D-glucuronide) and xenobiotics leading to 
impaired canalicular BA excretion and subsequent excessive intracellular accumulation of 
BA (Stieger et al. 2000). These clinical adverse events appear to be associated with disturbed 
BA homeostasis due to altered BA elimination as key underlying toxicity mechanism. This 
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underscores the need for a more fundamental understanding of the exact role of BA 
accumulation mediated toxicity at the cellular level and in a quantitative manner.  
Serum BA concentrations of about 3 - 7 µM are considered as physiological (Scherer et al. 
2009; Tribe et al. 2009). When BA accumulate in hepatocytes above their physiological 
concentration range (which may or may not be associated with increased serum BA 
concentrations), they are associated with clinical hepatotoxicity. Higher BA concentrations 
(in the millimolar range) are thought to exert cytotoxicity by causing necrosis. However, in 
the lower range (µM range) of supra-physiological BA concentrations, bile acid-induced 
apoptosis is supposed to be the predominant mechanism (Perez and Briz 2009). Several 
mechanisms have been suggested to explain bile acid-induced apoptosis, such as: (i) direct 
activation of the death receptors Fas and TRAIL-R2, (ii) mitochondrial permeability 
transition induction and subsequent cytochrome c release and, (iii) mitochondrial and 
endoplasmic reticulum-mediated oxidative stress (Perez and Briz 2009). The toxicity 
associated with excessive BA accumulation results in impaired liver functions as observed in 
case of cholestasis. Higher plasma as well as hepatic bile acid concentrations has indeed been 
reported in case of cholestasis in both humans and rodents. In chronic cholestatic patients, 
hepatic bile acid concentrations as high as 430 µM have been estimated (Fischer et al. 1996; 
Rolo et al. 2003). Therefore, to gain insight into the toxicity exerted by BA in cholestasis, a 
thorough mechanistic investigation of concentration-dependent toxicity of BA in hepatocytes 
is of prime importance. 
Various experimental animal models are available for studying the pathophysiological 
alterations during intrahepatic cholestasis (Rodríguez-Garay 2003). However, it is not 
possible to accurately control and measure the (hepatic) bile acid concentrations in vivo. In 
contrast, cell-based in vitro systems can provide insight into the role of individual bile acid 
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species (and/or their metabolites) in causing hepatotoxicity when their concentrations are 
elevated.   
Bile acid-mediated toxicity has been studied in different in vitro systems including isolated 
rat liver mitochondria, cell lines (as HepG2), and isolated hepatocytes in suspension and in 
conventional primary cultures of rat hepatocytes (Hillaire et al. 1995; Martinez-Diez et al. 
2000; Rolo et al. 2004; Rolo et al. 2002; Spivey et al. 1993). However, these in vitro systems 
only partly reflect the intricate interplay between uptake and efflux transporters and the 
metabolizing enzymes that takes place inside the liver, to regulate the intracellular bile acid 
concentration. Sandwich-cultured hepatocytes (SCH) represent an in vitro model that 
maintains this expression of relevant basolateral and canalicular transporters. In addition, 
cultured hepatocytes have been reported to contain the necessary enzymes such as BAAT 
(bile acid-N-acetyl transferase), which mediates conjugation of unconjugated BA with either 
glycine or taurine (Falany et al. 1994; Rembacz et al. 2010). SCH are therefore an excellent 
model to provide further evidence for the link between bile acid-mediated toxicity and 
intracellular hepatic exposure to these BA or their conjugates. 
In sandwich-cultured rat hepatocytes (SCRH), the expression/activity level of the different 
enzymes and transporters changes with culture time: while it has been reported that Ntcp 
expression gradually decreases, Bsep expression gradually increases (De Bruyn et al. 2013; 
Kotani et al. 2011). Functional bile canaliculi are fully developed in SCRH by day-3 after 
seeding (Liu et al. 1998). Hence, it is expected that Bsep-mediated bile acid efflux will 
constitute an elimination mechanism in day-3 but not in day-1 SCRH. Therefore, we 
hypothesized that the (apparent) toxicity of the BA will decrease with culture time because of 
more effective elimination (and/or less uptake). This implies that intracellular BA 
concentrations are expected to be lower in day-3 compared to day-1 SCRH.  
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In the present study, the BA toxicity in SCRH [as determined with an assay reflecting (loss 
of) hepatocyte-specific function] was linked for the first time to the in vitro hepatobiliary 
disposition profiles of these BA (and their metabolites/conjugates). A comparison of hepatic 
disposition and toxicity of BA was made between day-1 and day-3 SCRH. This revealed 
novel insight regarding a putative link between toxicity of certain bile acid species and the 
intracellular levels they reach in cultured hepatocytes.  
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2. Materials and methods 
2.1. Materials 
William’s E Medium (WEM), L-glutamine, penicillin-streptomycin mixture (contains 10,000 
IU penicillin and 10,000 IU of streptomycin per ml), Fetal Bovine Serum (FBS), Hanks’ 
Balanced Salt Solution (HBSS), Ca++/Mg++-free HBSS, Phosphate Buffered Saline (PBS; 1x 
and 10x), Trypan blue solution (0.4%) were purchased from Lonza Verviers SPRL (Verviers, 
Belgium). ITS +™ Premix (contains insulin 6.25 mg/l, transferin 6.25 mg/l, selenious acid 
6.25 mg/l, bovine serum albumin 1.25 g/l  and linoleic acid 5.35 mg/l) was purchased from 
BD Biosciences (Erembodegem, Belgium). Sulfuric acid (95-97%) was purchased from 
Chem-Lab NV (Zedelgem, Belgium). All the BA, collagenase type IV (from Clostridium 
histolyticum), recombinant human insulin, Triton X-100, dexamethasone, urea, diacetyl 
monoxime, thiosemicarbazide, iron (III) chloride hexahydrate, ortho-phosphoric acid, 
ethylene glycol-bis(2-aminoethylether)-N,N,N´, N´-tetraacetic acid (EGTA)  were purchased 
from Sigma-Aldrich (Schnelldorf, Germany). HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) was purchased from MP Biochemical (Illkirch, France). 
Thermostable 96-well plates were kindly provided by Greiner Bio-One BVBA (Wemmel, 
Belgium). Collagen was prepared in-house from rat tails according to established procedures. 
For incubations with sandwich-cultured hepatocytes described below, ‘standard buffer’ 
consisted of HBSS adjusted to pH 7.4 and ‘Ca++/Mg++-free buffer’ consisted of Ca++/Mg++-
free HBSS containing 1 mM EGTA (adjusted to pH 7.4). 
2.2. Animals  
The rats were housed according to the Belgian and European laws, guidelines and policies for 
animal experiments, housing and care in the Central Animal Facilities of the university. 
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Approval for this project was granted by the Institutional Ethical Committee for Animal 
Experimentation. 
2.3. Isolation of rat hepatocytes  
Hepatocytes were isolated from male Wistar rats (170-200 g) based on a two-step collagenase 
perfusion method, as described previously (Annaert et al. 2001), without adding trypsin 
inhibitor. After isolation, cells were centrifuged (50 g) for 3 min at 4°C and the pellet was re-
suspended in William’s E medium containing 5 % FBS, 2 mM L-glutamine, 100 IU/ml 
penicillin, 100 IU/ml streptomycin, 4 µg/ml insulin, and 1 µM dexamethasone. Hepatocytes 
were counted using a hemocytometer and cell viability was determined using Trypan blue. 
Cells were re-suspended in WEM and diluted to a final concentration of 1 x 106 cells/ml. 
Hepatocytes used in experiments had a viability after isolation of at least 85%.  
2.4. Sandwich-cultured rat hepatocytes 
 24-well/6-well plates were coated with ice-cold collagen solution (~ 1.5 mg/ml final 
concentration: 50 µl/well for 24-well; 150 µl/well for 6-well plates) prepared by neutralizing 
a mixture of 4 ml of rat-tail collagen, 4 ml of deionized water, and 1 ml of 10 x Dulbecco’s 
modified Eagle’s medium with ~ 1 ml of 0.2 N NaOH (final pH ~ 7.4), and placed overnight 
at 37°C in a humidified incubator. Three hours before seeding, each well was hydrated with 
500 µl (2 ml/well for 6-well plates) of PBS at 37oC. In 24-well plates, hepatocytes were 
seeded at a density of 0.5 x 106 cells/well (0.26 million cells/cm2) while in 6-well plates 1.75 
x 106 cells/well in seeding medium (for 24-well 500 µl/well, while for 6-well plates 2 
ml/well), which consists of WEM containing 5% FBS, 100 IU/ml penicillin, 100 IU/ml 
streptomycin, 4 µg/ml insulin, and 1 µM dexamethasone. After incubating the cells at 37°C 
in a humidified atmosphere with 5% CO2 (Binder CO2 incubator, Binder GmbH) for 1-2 h, 
unattached cells were removed by gently swirling the plate and immediately aspirating the 
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medium. To obtain a “sandwich” configuration the cells were overlaid with 50 µl and 200 µL 
of rat tail collagen solution (~1.5 mg/ml, pH 7.4) for 24 and 6-well plates respectively, (“day 
0”). One hour later, completed cell culture medium at 37oC was added onto the cultures 
which were kept in a humidified atmosphere with 5% CO2. The medium was changed every 
day with culture medium consisting of, WEM containing 1% (v/v) ITS +™ Premix, 100 IU/ml 
penicillin, 100 IU/ml streptomycin, and 0.1 µM dexamethasone. 
2.5. Determination of urea formation in SCRH  
To determine the urea synthesis capacity in SCRH, culture medium was aspirated and 
hepatocytes were rinsed twice with HBSS at 37°C. The cells were then incubated with HBSS 
containing 10 mM HEPES, 2 mM glutamine, 10 mM ammonium chloride and 3 mM 
ornithine (250 µl/well for 24-well plates) for 1 h at 37°C in a humidified atmosphere with 5% 
CO2. After 1 h of incubation, 60 µl of the incubation medium/well was mixed with 240 µl of 
color reagent (see below) in a 96-well thermostable plate. The mixture of color reagent and 
incubate was heated at 85°C for 20 min in a water bath and subsequently cooled down by 
keeping the plate at 4°C for 10 min. Absorbance was measured at 525 nm using a Tecan 
Infinite M200 plate reader (Austria). The color reagent was prepared by mixing the following 
solutions A and B in 2:1 ratio (v/v) just before the measurement. Solution A: 30 ml of 
concentrated sulfuric acid and 10 ml orthophosphoric acid added slowly to 60 ml of ferric 
chloride solution (160 mg/l FeCl3.6H2O) and mixed gently; the solution was kept on ice. 
Solution B:  A 1:1 mixture of 60 mg thiosemicarbazide in 100 ml of ELGA water and 1200 
mg diacetyl monoxime dissolved in 100 ml ELGA water. 
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2.6. Bile acid toxicity determination 
Toxicity determination of the selected BA was carried in two stages. First, toxicity of the BA 
was evaluated in day-1 SCRH. Subsequently, the BA showing toxicity in day-1 SCRH, were 
further evaluated for culture-time dependent toxicity (day-1 versus day-3 SCRH). 
2.6.1. Toxicity of BA in day-1 SCRH 
Toxicity of the BA in SCRH was determined based on their influence on the ability of SCRH 
to convert toxic ammonia to urea. BA at different concentrations (5, 50, 100, 500 and 1000 
µM for CDCA, GCA; 5, 50, 100, 250 and 500 µM for DCA and the equimolar mixture of 
CA, CDCA and DCA; 5, 50, 100, 200, 350, 500 and 1000 µM for UDCA and GCDCA) were 
incubated with day-1 SCRH (24 h after seeding). After 24 h of incubation with the BA, urea 
formation was determined (at day-2).  
2.6.2. Comparison of bile acid toxicity between day-1 and day-3 SCRH  
Bile acid toxicity was compared between day-1 and day-3 SCRH in two batches of rat 
hepatocytes. For this purpose, CDCA and DCA at 5, 50, 100, 150, 200, 250, and 500 µM and 
5, 50, 100, 200, 350, 500 and 1000 µM of UDCA and GCDCA were incubated with day-1 
and day-3 SCRH. After 24 h of incubation with BA, urea formation was measured at day-2 
and day-4. DMSO content was normalized to 0.3% for each condition.  
2.7. Measurement of accumulation of CDCA, DCA and their taurine and glycine conjugates 
To reveal a possible relation between BA toxicity and intracellular exposure of hepatocytes to 
BA, CDCA and DCA were incubated for 30 min (CDCA only) or 4 h with day-1 and day-3 
SCRH. Following 30 min / 4 h incubation, the incubation medium was aspirated and the 
hepatocytes were rinsed twice with either standard or Ca++/Mg++-free buffer at 37°C. 
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Subsequently, hepatocytes were incubated for 10 min (37°C) with either standard or 
Ca++/Mg++-free buffer (B-CLEAR® procedure, Qualyst Transporter Solutions, Durham, NC). 
Next, incubation buffer was aspirated (collected for further analysis in one of efflux studies, 
see below for sample preparation) and cells were immediately rinsed four times with ice-cold 
standard buffer. Hepatocytes were then harvested with a chilled (-20°C) 7:3 mixture of 
methanol:water, containing 1 µM d4-cholic acid (d4-CA) as internal standard, and centrifuged 
at 14000 rpm for 15 min. After centrifugation, supernatants were collected and kept at -20°C 
till analysis by LC-MS (/MS). For determination of the total formation and sinusoidal efflux 
of GCDCA and TCDCA (Figure 3), the culture medium was collected immediately after 
incubation of the day-1 and day-3 SCRH with CDCA. Subsequently, the cells were rinsed 
three times with standard buffer at 4°C, following harvesting the SCRH according to the 
above mentioned procedure. The collected medium samples were diluted with two volumes 
of a 7:3 mixture of methanol:water, containing 1 µM d4-CA as internal standard, and 
centrifuged at 14000 rpm for 15 min. After centrifugation, supernatants were collected and 
kept at -20°C till analysis by LC-MS (/MS). 
The supernatants collected after 10 min incubation with either standard or Ca++/Mg++-free 
buffer were diluted two times with 7:3 mixture of methanol:water, containing 1 µM d4-CA as 
internal standard, and centrifuged at 14000 rpm for 15 min. After centrifugation, supernatants 
were collected and kept at -20°C till analysis by LC-MS (/MS). 
2.8. LC-MS analysis   
Bile acid analysis was performed either with a Waters LC-MS system (Milford, MA, USA) 
or a Thermo Fisher Scientific LC-MS/MS system (Thermo Fischer, Breda, The Netherlands). 
The Waters system consisted of an HT alliance HPLC component and Micromass ZQ MS 
component with ESI source. The Thermo Fisher Scientific system consisted of a TSQ 
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Quantum AccessTM mass spectrometer coupled with AccelaTM U-HPLC system (Thermo 
Fischer, Breda, The Netherlands). For analysis in the Waters LC-MS system, separation was 
achieved with a Phenomenex Gemini C18 column (3 µ, 150 x 4.6 mm) with matching guard 
and pre-column, at a flow rate of 400 µl/min. The injection volume was 25 µl. The mobile 
phase was 15% methanol, 15% ammonium formate with formic acid (pH adjusted to 3.5) and 
70% acetonitrile for 12 min. For analysing BA in the Thermo Fisher Scientific LC-MS/MS 
system, a Kinetex C18 column (1.7 µ, 100A, 50 x 3 mm) with a KrudKatcher ultra HPLC in-
line filter (PhenomenexR, The Netherlands) was used to achieve optimum separation. The 
injection volume was 10 µl. The chromatographic conditions were: 300 µl/ min flow rate for 
3 min, with mobile phase consisting of 80:20 methanol:5 mM ammonium formate buffer (pH 
adjusted to 3.5 with formic acid). Analytical methods were validated for reproducible 
quantification of (i) CDCA and its conjugates, and (ii) DCA and its conjugates, with nominal 
QC sample concentrations of 0.05, 0.5 and 2 µM. Analysis was done in the negative 
electrospray ionization mode. The interday inaccuracy varied between +0.31 % and -5.97 % 
and +1.96 % and +4.78 % for analysis of CDCA + conjugates and DCA + conjugates, 
respectively. The reproducibility as measured by % CV was 0.55 -9.19 % for CDCA and 
conjugates, and 3.4-5.22 % for DCA and conjugates. The interday inaccuracy of the analysis 
using the Thermo LC-MS/MS system for CDCA + conjugates group varied between -4.87 % 
to +7.87 %, while that for DCA + conjugates was +1.21 % to -7.08 %. The reproducibility (% 
CV) for analysis at different days was 3.77 - 13.41 % for BA in the CDCA group, while it 
was 1.96 to - 10.12 % for BA in the DCA group. BA concentrations in samples were 
determined by calculating the area ratio of analyte to internal standard.  The monitored 
mass/charge ratios and transitions are included in Table 1a and Table 1b, respectively. 
2.9. Data analysis 
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The Emax model was used to describe the concentration-dependency of the inhibitory effect 
of various BA on the capacity of hepatocytes to convert urea: 
 
Where E is the urea production by hepatocytes, Emax is the urea production under control 
condition (without inhibitor), E0 is the urea production at the maximum inhibitory effect of 
inhibitor, (Emax – E0) is the maximum inhibitory effect. The IC50 is the bile acid concentration 
causing a 50% inhibition. The parameter “n” denotes the Hill factor. The best fits of the 
above equation to the individual urea formation data sets were obtained by non-linear 
regression analysis with the NLS2 package in R version 2.15.1. The inverse of the 
experimentally obtained standard deviations were used for weighing. 
In the absence of Ca++/Mg++ the tight junctions between hepatocytes are disrupted, resulting 
in release of biliary content from the canalicular space (Liu et al. 1999). The accumulation 
values obtained from wells treated with Ca++/Mg++-free buffer were considered to reflect 
intracellular BA accumulation only. The amounts excreted in bile canaliculi was determined 
by subtracting the amounts of BA in cell lysates prepared from cultures treated with 
Ca++/Mg++-free buffer from that measured in cultures treated with standard buffer. 
Intracellular bile acid concentrations were estimated by dividing amounts of intracellularly 
accumulated bile acid by intracellular hepatocytes volume. The hepatocyte volume used to 
calculate intracellular BA concentrations (6.34 pl/cell) was based on the mean rat hepatocyte 
cellular volume as previously reported in two different studies (Brouwer 2010; Uhal and 
Roehrig 1982). 
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For calculating the biliary excretion of BA, a Biliary Excretion Index (BEI) was calculated 
according to the following equation (Liu et al. 1999), (B-CLEAR® procedure, Qualyst 
Transporter Solutions, Durham, NC) : 
 
Canalicular Efflux Index (CEI) was calculated according to the following equation: 
 
2.10. Statistics  
ANOVA F-test (in MS Excel version 2007) was used to evaluate statistical significance of 
differences between day-1 and day-3 toxicity profiles (Figure 1) as well as accumulation 
(Figure 2, and 4) profile curves of BA, by comparing separately fit profiles for each culture 
day versus the simultaneous fit obtained with day-1 and day-3 measurements combined 
(Gibson et al. 1994). The criterion for statistical significance was p < 0.05.  
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3. Results 
3.1. Comparison of bile acid toxicity between day-1 and day-3 SCRH 
The effect of culture time (day-1 versus day-3 cultures) on BA toxicity was evaluated for 
CDCA, DCA, UDCA and GCDCA in two batches of hepatocytes (Figure 1). Higher BA 
concentrations were required in day-3 cultures, as compared to day-1 cultures, to decrease the 
urea formation to the same extent. This implied that BA were significantly more toxic in day-
1 SCRH than day-3 SCRH (p < 0.05 for the difference of the toxicity profiles between day-1 
and day-3 SCRH). The cytotoxicity differences are reflected by the significantly higher IC50 
values obtained for day-3 versus day-1 SCRH in both batches of SCRH (Table 2).  
3.2. Accumulation of CDCA, DCA and their conjugates upon extracellular exposure of day-1 
and day-3 SCRH to CDCA and DCA 
As differences in bile acid toxicity between day-1 and day-3 hepatocyte cultures are possibly 
related to different intracellular accumulation and thus exposure to BA, concentration 
dependent accumulation of CDCA and DCA (including their formed conjugates) was 
determined. For this purpose, hepatocytes were incubated with CDCA and DCA at 4 different 
concentrations covering the NOAEL based on the toxicity data presented in Figure 1. Figure 
2 depicts mean (± SEM) values for bile acid accumulation after 4 h exposure to 5, 25, 50 or 
100 µM of CDCA or DCA, in three different batches of SCRH. Note that the 4 h incubation 
with bile acids in culture medium was followed by a rapid rinsing of the cells and subsequent 
10 min incubation with standard buffer. This particular incubation design was used for 2 
reasons: (i) it allowed to directly compare the obtained accumulation data to those obtained 
following incubation of the hepatocytes for 4 h + 10 min in Ca++/Mg++-free buffer (see 3.4); 
(ii) it allowed to focus on those bile acid(s) (metabolites) showing substantial retention in 
hepatocytes (i.e. not subject to efficient sinusoidal efflux). 
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Figure 2 illustrates that the hepatocytes converted the administered unconjugated BA (CDCA 
and DCA) to corresponding glycine and taurine conjugates. The combined amounts of CDCA 
and its two conjugates GCDCA and TCDCA that had accumulated in cells (+ bile canaliculi 
in case of day-3 cultures) after 4 h exposure to 5, 25, 50 or 100 µM of CDCA (and followed 
by 10 min efflux in either standard or Ca++/Mg++-free buffer) are shown in Figure 2A. The 
corresponding data following exposure to DCA are shown in Figure 2E. The combined bile 
acid levels did not differ significantly between day-1 and day-3 SCRH for both CDCA and 
DCA group of BA. However, as illustrated in Figure 2B for CDCA and Figure 2F for DCA, 
significantly higher levels (p<0.05) of these unconjugated BA were observed in day-3 
compared to day-1 hepatocytes, for all incubation concentrations (except 5 µM). 
Interestingly, the opposite was observed for the respective glycine and taurine conjugates, 
that reached higher accumulation in day-1 SCRH compared to day-3 SCRH, when exposed to 
the respective unconjugated BA (Figure 2 C-D, for CDCA conjugates and Figure 2 G-H for 
DCA conjugates).  Figure 2D and 2H further illustrate that 4 h exposure to (C)DCA results in 
~ 10 - 20 times lower taurine conjugate levels as compared to glycine conjugate levels.  
3.3. Effect of culture time on formation and sinusoidal efflux of GCDCA and TCDCA in day-
1 and day-3 SCRH 
Subsequent incubations were conducted to delineate the exact roles of bile acid conjugation 
and/or sinusoidal efflux of bile acids as underlying mechanisms in culture time-dependent 
bile acid disposition. For this purpose, day-1 and day-3 hepatocytes were exposed to different 
concentrations of CDCA for 4 h, before measuring CDCA (and conjugate) levels in both 
hepatocyte cultures and the medium. Importantly, the 10 min incubation with standard buffer 
(which was included for the data presented in Figure 2), was now omitted. Instead, not only 
intracellular bile acid levels but also bile acid levels in the medium were measured at the end 
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of the 4 h incubation period. Thus, total conjugating capacity towards BA could be assessed 
for the various CDCA concentrations in both day-1 and day-3 cultures (Figure 3A and 3C for 
GCDCA and TCDCA). Note that total conjugate levels were plotted against intracellular 
CDCA concentrations (X-axis) as these constitute the driving force for BA conjugation. 
Intracellular concentrations were calculated based on measured intracellular CDCA amounts 
and estimated total intracellular hepatocyte volume (Brouwer 2010; Uhal and Roehrig 1982). 
Figure 3A/C confirms that after 4h exposure to CDCA, glycine and taurine conjugate levels 
in day-1 hepatocytes clearly exceeded those in day-3 hepatocytes for intracellular CDCA 
concentrations above 20 µM. Furthermore, the conjugate formation rates (essentially total 
amounts formed/4h, Figure 3A/C) exhibited saturation within the studied concentration 
range, irrespective of the days in culture of the hepatocytes. Figure 3B/D depicts 
corresponding medium concentrations (µM) of GCDCA and TCDCA as measured 
immediately after this 4h exposure. These profiles essentially reflect sinusoidal conjugate 
efflux that occurred during the 4h incubation period. It is important to note that these medium 
data reveal a similar saturation pattern as compared to the total formation data. Also similar 
to their total formation profiles, GCDCA and TCDCA concentrations were about 2 times 
higher in the medium of day-1 SCRH compared to day-3 SCRH, at intracellular CDCA 
concentrations of 20 µM onwards. 
 3.4. In vitro biliary excretion of CDCA/ DCA and their conjugates 
Apart from elimination by conjugation (and subsequent sinusoidal efflux), BA added to day-3 
(but not day-1) SCRH may also undergo in vitro biliary excretion. To further explore the 
contribution of this elimination mechanism, SCRH were first exposed to CDCA or DCA for 
4h; subsequently, the medium was rinsed off and hepatocytes were incubated for 10 min with 
either standard or Ca2+/Mg2+-free buffer. For a selected batch of day-3 SCRH, the combined 
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mean (± SD) amounts of CDCA and its two conjugates (TCDCA and GCDCA) accumulating 
in cells and bile networks (standard buffer), were measured to be higher than in cells only 
(Ca2+/Mg2+-free buffer) (Figure 4A, p<0.05). Also, the individual amounts of CDCA and 
GCDCA (Figure 4B-C) were found to be higher in cells and bile pockets, compared to cells 
only (p<0.05). Combined and individual amounts of DCA and GDCA (Figure 4 D-F) were 
higher in cell and bile pockets compared to cells only (p<0.05). It should be recognized that 
bile acid accumulation in standard versus Ca2+/Mg2+-free buffer treated cells did not differ 
significantly in two other batches of SCRH (data not shown).  
3.5. Biliary Disposition of CDCA and DCA in day-3 SCRH 
Results presented in Figures 2-4 indicate that in vitro elimination of the bile acids CDCA and 
DCA in SCRH occurs via two distinct pathways: (i) bile acid conjugation (Figure 2); (ii) and 
direct biliary excretion. In order to illustrate the role of latter elimination route for CDCA and 
DCA, biliary excretion data for the batch of SCRH presented in Figure 4 were plotted, as 
shown in Figure 5. In contrast to the clear saturation of conjugate formation (Figure 2), 
biliary excretion of unconjugated (C)DCA did not reveal saturation.  
3.6. Disposition of GCDCA and GDCA in day-3 SCRH 
After formation, the conjugates of CDCA and DCA also get excreted into the bile networks. 
Figure 6A illustrates that upon 4 h exposure to CDCA (followed by 10 min efflux phase), the 
intracellular levels of GCDCA were found to increase with extracellular CDCA concentration 
up to 100 µM. In contrast, the biliary excretion of GCDCA did not increase proportionally 
beyond 25 µM of CDCA (Figure 6A). The maximum amount of GCDCA in bile was 
detected at 25 µM of extracellular CDCA exposure. Accordingly, the BEI of GCDCA was 
found to decrease with increasing intracellular concentration of GCDCA (Figure 6B). For 
GDCA, the amount excreted into the bile was also measured to be lower than the intracellular 
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amount of GDCA at each extracellular DCA concentration (Figure 6C-D), but no clear 
saturation was observed. For GDCA, the BEI appeared to remain more or less constant (27-
35%) (Figure 6D).  
3.7. Disposition of CDCA and conjugates in day-4 SCRH 
As mentioned before, the extent of biliary excretion of (C)DCA and their conjugates in day-3 
SCRH exhibited considerable interbatch variability. Therefore, an adapted incubation design 
was used to confirm the biliary excretory capacity for CDCA and its conjugates in day-4 
SCRH. For this purpose, sinusoidal and canalicular efflux (10 min) of CDCA (and GCDCA) 
was determined in day-4 SCRH (seeded in 6-well plates) that had been exposed to various 
concentrations of CDCA for 4 h. Amounts of CDCA and GCDCA that were effluxed in the 
extracellular buffer during the 10 min incubation were much higher for Ca2+/Mg2+-free buffer 
as compared to standard buffer throughout the concentration range 5-100 µM (Figure 7). A 
canalicular efflux index (CEI), representing the relative contribution of canalicular efflux to 
overall efflux was calculated based on the efflux data shown in Figure 7. The CEI values 
varied between 76-82 % for CDCA, while for  GCDCA it varied between 78 and 81 %. In 
line with accumulation data, efflux of TCDCA was about 10 times less than the efflux of 
GCDCA. 
3.8. Effect of incubation time on disposition of CDCA in day-1 and day-3 SCRH 
In a final set of experiments, the time dependency of CDCA accumulation and conjugation in 
day-1 versus day-3 SCRH was determined. Relative (and absolute) amounts of TCDCA and 
GCDCA that accumulated (and remained) in the hepatocytes were found to be different after 
30 min as opposed to 4 h incubation (always followed by 10 min efflux) with CDCA. After 
30 min incubation (followed by 10 min efflux) with CDCA, higher levels of TCDCA were 
seen as compared to GCDCA, while after 4 h incubation, the opposite was observed (see also 
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Figure 2-3). This phenomenon was observed at each concentration of extracellular exposure 
(5, 25, 50 and 100 µM) of CDCA and in both day-1 (column A of Figure 8) and day-3 
(column B of Figure 3) SCRH. The combined accumulated amounts of CDCA and its 
conjugates (CDCA+GCDCA+TCDCA) in cell and bile networks decreased with time (30 
min accumulation > 4 h accumulation), at all concentrations. Compared to levels observed at 
day-1, much higher levels of unconjugated CDCA were observed in day-3 cultures, 
irrespective of incubation time.  
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4. Discussion  
The array of cellular and molecular mechanisms involved in the development cholestatic 
disease remains elusive. However, excessive intrahepatic accumulation of BA and/or their 
metabolites is thought to play a major role in this respect. As discussed in the introduction, 
intracellular bile acid levels in the liver are the result of intricate influences of hepatic BA 
metabolism along with hepatic uptake and efflux processes. Using sandwich-cultured rat 
hepatocytes, we presently provide novel evidence regarding the link between (excessive) 
intracellular bile acid accumulation and compromised hepatocyte viability and function. 
Moreover, in view of the dynamic changes in (relative) activities of enzymes and transporters 
involved in BA disposition, we hypothesized that exogenously added BA would exert their 
cytotoxic effect in SCH in a culture time-dependent fashion. The fact that SCH require 
several days for re-establishing functional bile canalicular networks, strongly suggests that 
this bile acid-eliminating capacity will be higher in day-3 versus day-1 SCRH. Our present 
observation (Figure 1) that bile acid-induced cytotoxicity in SCRH was indeed significantly 
lower in biliary excretion-competent (i.e. day-3) hepatocytes corroborates this concept of 
culture time-dependent capacity in bile acid handling. At the same time, quantifying 
intracellular bile acid levels following extracellular exposure of day-1 versus day-3 SCRH to 
exogenously added BA becomes an attractive approach to further explore the putative bile 
acid exposure-toxicity association. A particular advantage of this approach includes the fact 
that the use of transporter and/or enzyme inhibitors (with often questionable specificity) of 
hepatic bile acid disposition processes can be circumvented.  
In the present work, compromised urea formation capacity was chosen as indicator to 
evaluate the concentration-dependency of in vitro cytotoxicity of BA - added individually or 
as a mixture - in SCRH. Determination of urea formation by bile acid-exposed hepatocytes 
enables detecting (sub-lethal) reduction in hepatocyte functionality (Dabos et al. 2004; Poll et 
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al. 2006). To efficiently measure urea formation in SCRH for our purpose, the well-known 
urea assay (Goeyens et al. 1998) was first miniaturized to a higher throughput 96-well 
format. We presently show that among all BA evaluated, glycine-conjugated BA were most 
potent in reducing the urea formation rate in day-1 SCRH upon 24 h exposure 
(Supplementary Figure 1). Consistently, several earlier in vitro observations in rat 
hepatocytes (Patel et al. 1994; Spivey et al. 1993) illustrated that glycine-conjugated BA 
were more toxic than their unconjugated or taurine-conjugated counterparts. This result 
supports the validity of the urea assay for the purpose of the present study. 
Concentration-dependent accumulation (Figure 2) of CDCA and DCA (including their 
glycine/taurine conjugates) was studied, both after 1 day and 3 days in culture, in three 
batches of SCRH, at concentrations around the in vitro NOAEL for these BA (5-100 µM). 
For this part of the study, a 4 h exposure period (rather than 24 h used for toxicity 
assessments) was selected to achieve low/moderate toxicity but avoid excessive cell death as 
this could mask the hepatic BA disposition processes. When “total” accumulation of BA was 
compared between day-1 and day-3 SCRH (Figure 2A/E), no statistically significant 
differences were found. This may appear contrary to the knowledge that there is a culture 
time-dependent decrease in uptake transporter activity and simultaneous increase in 
sinusoidal efflux transporter activity (De Bruyn et al. 2013; Liu et al. 1998). Moreover, 
accumulation values of the unconjugated BA species CDCA and DCA were actually higher 
in day-3 versus day-1 SCRH. This indicates that CDCA and DCA do not play a major direct 
role in the culture time-dependent decrease in toxicity (Figure 1) that was observed when 
SCRH were exposed to these BA. While (C)DCA accumulation increased with culture time, 
the opposite was observed for the corresponding glycine conjugates [accumulation in day-1 > 
day-3]; and this compensated more or less for the differences in accumulation observed for 
the “parent” (unconjugated) BA. Interestingly, the more than proportional increase in CDCA 
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and DCA accumulation (Figure 3B/F) with increasing extracellular exposure to these BA (5-
100 µM), was consistent with the saturation kinetics in the formation of the glycine 
conjugates. This is illustrated by the simultaneously fitted accumulation profiles obtained for 
unconjugated BA and their corresponding glycine conjugates (Supplementary Figure 2). 
Taken together, the substantially higher levels of glycine conjugates of CDCA and DCA in 
day-1 as compared to day-3 cultures (Figure 2C and 2G) suggests that these glycine 
conjugates play an important role in the toxicity differences when SCRH of different days in 
culture are exposed to the unconjugated CDCA and DCA.  
The reduced glycine conjugate levels in day-3 SCRH may result from: (i) culture time-
dependent decrease in overall formation of glycine conjugates, and/or (ii) increased 
basolateral efflux of these conjugated BA in day-3 cultures. In order to delineate between 
these two mechanisms, total conjugate levels in SCRH were assessed by analyzing both the 
culture medium and the hepatocytes (including bile networks, in case of day-3 SCRH) 
following a 4 h exposure to 5-100 µM CDCA (Figure 3 A/C). These data clearly illustrate 
that total amounts (cells + medium) of formed GCDCA and TCDCA were higher in day-1 
compared to day-3 SCRH for intracellular CDCA concentrations above 25 to 100 µM. A very 
similar pattern was observed when only medium conjugate concentrations were plotted 
against intracellular CDCA concentration (Figure 3 B/D). This is consistent with non-
restrictive efflux of BA conjugates via basolateral efflux transporters. This also means that 
the lower intracellular levels of BA conjugates in day-3 SCRH cannot be explained in terms 
of a culture time-dependent increase in sinusoidal efflux. It is noteworthy that the elevated 
glycine conjugate levels were observed for CDCA incubation concentrations above 25 µM. 
This corresponds to the concentration range around which CDCA becomes toxic in day-1 
(but not day-3) SCRH (Figure 1). Therefore, decreased formation of glycine conjugates (but 
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not increased sinusoidal efflux) in day-3 cultures appears to be the major mechanism 
explaining reduced glycine conjugate levels in day-3 cultures as shown in Figure 2 C/D.    
Further to BA metabolism by conjugation, biliary excretion of BA will also contribute to 
their hepatic elimination. As mentioned earlier, both these elimination pathways are taking 
place in SCH. Intracellular and intracanalicular bile acid accumulation were determined via 
the B-CLEAR® method as explained in the materials and methods and results section 
(Annaert and Brouwer 2005; Annaert et al. 2001; Liu et al. 1999). As illustrated in Figure 
4A-C for CDCA and in Figure 4D-F for DCA, up to about 50% of the accumulated amounts 
of BA (including conjugates) were residing in bile canalicular compartments. Figure 5 
provides a direct comparison of the importance of CDCA and DCA biliary excretion in 
hepatic elimination. For both CDCA and DCA, biliary excretion rates continue to increase up 
to intracellular concentrations of 300 µM. Also GDCA showed non-saturable biliary 
excretion for intracellular GDCA concentrations up to 100 µM (Biliary excretion index, BEI 
= 27-35%; Figure 6D). In contrast, clear saturation of biliary excretion was observed for the 
glycine conjugate of CDCA, as reflected by decreasing BEI values (from 62% down to 21%) 
for intracellular GCDCA concentrations between 3 and 80 µM. 
Although conjugated bile acid levels were found to be very similar in three batches of SCRH, 
considerable interbatch variability was observed with respect to biliary excretion of CDCA, 
DCA and their conjugates. The inter-batch variability in biliary excretion may result from 
different factors. Pulsatile and/or cyclic release of canalicular contents by sandwich-cultured 
hepatocytes may be one of these factors (Brouwer et al. 2007). Indeed, within the 4 h bile 
acid exposure time frame, different batches may show dissimilar bile canalicular release 
profiles. This implies low values for measured excretion in at least some batches of SCRH. 
Another factor causing interbatch variability in biliary excretion might involve variable 
extents of sinusoidal BA efflux in SCRH (Jemnitz et al. 2010), in turn affecting biliary 
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excretion rates. Efficient sinusoidal efflux during and immediately after the 4 h incubation 
(cfr. glycine conjugate medium concentrations shown in Figure 2), may have prevented 
accurate and consistent assessment of biliary excretion. Hepatocytes may indeed upregulate 
sinusoidal efflux in situations where canalicular excretion clearance becomes insufficient to 
get rid of rising intracellular bile acid levels; under those conditions, biliary excretion of BA 
is likely to become more variable across different batches of SCRH (Donner and Keppler 
2001). A third factor potentially contributing to variable BA excretion relates to the 
incubation design used in the present study. A 4 h exposure of the SCRH to BA was followed 
by a 10-min incubation with either standard or Ca++/Mg++-free buffer. This allowed releasing 
canalicular contents specifically in hepatocyte cultures exposed to Ca++/Mg++-free buffer. 
However, during this 10-min incubation periods concomitant sinusoidal efflux is continuing, 
which further contributes to decreasing differences in residual bile acid levels between 
hepatocytes exposed to standard versus Ca++/Mg++-free buffer.  
The BA efflux data (Figure 7) obtained after exposure of SCRH to various CDCA 
concentrations, showed higher sinusoidal + canalicular BA efflux (SCRH exposed to 
Ca++/Mg++-free buffer) as opposed to sinusoidal efflux (SCRH exposed to standard buffer). 
Moreover, corresponding BA accumulation data for these day-4 SCRH revealed some biliary 
excretion, mainly of GCDCA when higher CDCA concentrations were used (supplementary 
Figure 3). Taken together, these data suggest that direct measurement of differential bile acid 
efflux in addition to differential bile acid accumulation provides a reliable approach for 
determining in vitro biliary excretion of these BA in SCRH. Figure 7 illustrates that biliary 
excretion of CDCA increases more than proportional with increasing extracellular CDCA 
concentrations (consistent with concentration-dependent changes in intracellular levels; see 
Figure 2 and Figure 4). In contrast, GCDCA biliary excretion appears to be somewhat 
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reduced for CDCA concentrations > 50 µM, which is consistent with intracellular GCDCA 
concentrations that are leveling off after exposure to the higher CDCA concentrations. 
As discussed above, intracellular exposure to BA was first studied only after a 4 h exposure 
to CDCA or DCA, revealing much higher levels of glycine as compared to taurine 
conjugates. However, these values may be largely dependent on the incubation time and 
initial accumulation and metabolism of these BA may differ from the 4 h values. In this 
context, intracellular accumulation and metabolism of CDCA was compared for incubation 
times of 30 min and 4 h in SCRH (Figure 8). These data revealed that, irrespective of the 
culture time (day-1 or day-3), total levels of CDCA + glycine and taurine conjugates were 
higher after 30 min of incubation as compared to 4 h incubation. Depletion of extracellular 
CDCA by the end of the 4h incubation may explain this finding. Indeed, extracellular CDCA 
concentrations in the culture medium after 4 h incubation were reduced to between 20 % (5 
µM) and 50 % (100 µM) of the initial concentration (data not shown). The reduced 
intracellular accumulation after 4 h (as compared to 30 min) may also reflect adaptive 
response of the SCRH, e.g. upregulation of sinusoidal efflux mechanisms (Mrp3/4, Ost α/β) 
to protect hepatocytes in response to supraphysiological BA concentrations or decrease of 
uptake transporters by short-term feedback regulation (Alnouti 2009; Mühlfeld et al. 2012). 
Furthermore, bile acid metabolites may be formed that are not measured in our assay. Both 
sulfation and CYP-mediated metabolism have been reported to play a part in hepatic bile acid 
disposition (Alnouti 2009). Another remarkable finding was that the absolute and relative 
levels of the taurine conjugates of CDCA were much higher after 30 min incubations than 
after 4 h exposure. For instance, after exposure of day-1 SCRH to 25 µM CDCA, TCDCA 
accounted for more than 50% of total intracellular exposure (TCDCA>CDCA>GCDCA), 
whereas TCDCA levels were negligible following the 4 h exposure time. In line with the 
higher 4 h exposure values observed for GCDCA in day-1 versus day-3 cultures, 30 min 
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exposure values of particularly TCDCA were much higher in day-1 as compared to day-3 
cultures. As the incubation medium is composed primarily of Williams’ E Medium, 
containing 50 mg/L of glycine (but no taurine), it is possible that the intracellular source of 
taurine was depleted by 4 h, thus leading to increased formation of glycine conjugates. This 
has been suggested for cholic acid (Rembacz et al. 2010). However, this does not refute our 
explanation for the observed culture time-dependent toxicity, as the same composition of 
culture medium was used for day-1 and day-3 SCRH.  
To our knowledge, this is the first time that a possible link is revealed between bile acid 
toxicity and intracellularly formed glycine conjugate exposure in sandwich-cultured rat 
hepatocytes. We have demonstrated that the intrinsic toxicity of glycine conjugates is higher 
than for the corresponding taurine conjugates of CDCA, DCA. Toxicity of several BA in 
SCRH is clearly culture time-dependent, with toxicity at day-3 being less pronounced than at 
day-1. The lower intracellular exposure to the glycine conjugates (formed from CDCA and 
DCA) appears to be a key factor in the culture-time dependent decline in sensitivity of SCRH 
towards bile acid-mediated toxicity. The decreased intracellular exposure to glycine 
conjugates in older cultures can first be attributed to a decreased formation of glycine 
conjugates. In addition, day-3 SCRH benefit from the relative advantage of canalicular efflux 
of these formed glycine conjugates, thus further reducing the effective intracellular exposure 
to these toxic bile acid species. Assuming that glycine conjugates play a similar role in bile 
acid-mediated toxicity in human liver, our work has diagnostic and therapeutic implications 
for conditions of intrahepatic cholestasis in man.  
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Figure captions: 
Figure 1: Culture-time dependent toxicity of bile acids:  Day-1 (○) versus day-3 (Δ) toxicity 
profiles of CDCA, DCA, UDCA and GCDCA in two batches of SCRH (column A and B for 
batch-1 and 2 respectively), following 24 h incubation with these BA. The solid and the dotted 
lines represent the best fit of the sigmoid Emax model to the day-1 and day-3 toxicity in SCRH. 
Urea formation is expressed as the % control (hepatocytes treated with 0.3 % DMSO). The 
toxicity profiles of the four BA are significantly (p < 0.05) different between day-1 and day-3 
SCRH. 
Figure 2, Culture-time dependent accumulation of CDCA, DCA and their formed 
conjugates: A-D: Intracellular accumulation of: CDCA and its conjugates (A), CDCA (B), 
GCDCA (C), and TCDCA (D),  in day-1 (o) or day-3 (□) SCRH after incubating with 5, 25, 50 
and 100 µM of CDCA for 4 h, followed by 10 min incubation with standard buffer. E-H: 
Intracellular accumulation of: DCA and its conjugates (E), DCA (F), GDCA (G), and TDCA (H), 
in day-1 (o) or day-3 (□) SCRH after incubating with 5, 25, 50 and 100 µM of DCA for 4 h, 
followed by 10 min incubation with standard buffer. Data represent the mean (± SEM) 
accumulation in three different batches of SCRH (n=3, for TDCA n=2), each measured in 
triplicate. * indicates that the accumulation profiles are statistically significantly different from 
each other (p<0.05). 
Figure 3, Total formation and culture-medium concentration of GCDCA and TCDCA in 
day-1 and day-3 SCRH, cultured in 6-well plates: Total amounts (in hepatocytes + medium) of 
GCDCA (3A) and TCDCA (3B) and concentration of GCDCA (3C) and TCDCA (3D) in the 
culture-medium after incubation of day-1or day-3 SCRH with 5, 25, 50 and 100 µM of CDCA 
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for 4 h. The experiments were conducted in 6-well cell culture plates. Incubations were followed 
by analysis of BA in the medium and in the SCRH. Data represents mean (± SD) of triplicate 
measurements in a single batch of SCRH. Note that the x-axis represents intracellular CDCA 
concentrations after 4 h of incubation. 	  
Figure 4, Disposition of CDCA, DCA and their conjugates in day-3 hepatocytes: A-C: 
Amounts of CDCA and its conjugates (A), CDCA (B), GCDCA (C),  that accumulated in cells 
only (□), or in cells + bile networks (o) of day-3 SCRH after incubating with 5, 25, 50 and 100 
µM of CDCA for 4 h, followed by 10 min incubations with either Ca++/Mg++-free buffer (cells 
only) or standard buffer (cells + bile canaliculi). D-F: Amounts of DCA and GDCA (D), DCA 
(E), or GDCA (F), that accumulated in cells only (□), or in cells + bile networks (o) of day-3 
SCRH after incubating with 5, 25, 50 and 100 µM of DCA for 4 h, followed by 10 min 
incubations with either Ca++/Mg++-free buffer (cells only) or standard buffer (cells + bile 
canaliculi). Data represent the mean (± SD) accumulation of triplicate measurements in a selected 
batch of SCRH. * indicates that the accumulation profiles are statistically significantly different 
from each other (p<0.05). Taurine conjugate levels were around detection limit (see Figure 2) and 
therefore not plotted. 
Figure 5, Comparison between biliary excretion of CDCA and DCA in day-3 SCRH: 
Amount of unconjugated CDCA (□), or DCA (■), directly excreted in bile as a function of 
CDCA and DCA intracellular concentrations, after exposure to extracellular concentrations of 5, 
25, 50 and 100 µM of CDCA or DCA. After 4 h of incubation with CDCA/DCA, cellular and 
canalicular bile acid concentrations were determined following incubations with standard or 
Ca++/Mg++-free buffer for 10 min, as described in the materials and methods section. Points 
represent mean (± SD) of triplicate measurements in a selected batch of SCRH. 
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Figure 6, Disposition of GCDCA and GDCA in day-3 SCRH:  Cellular accumulation (o) and 
biliary excretion (□) of GCDCA (A and B), GDCA (C and D) after 4 h incubation of day-3 
SCRH with 5, 25, 50 and 100 µM of CDCA or DCA, followed by incubations with standard or 
Ca++/Mg++-free buffer for 10 min. BEI was calculated as described in materials and methods 
section. Data represents mean values (± SD) of triplicate measurements in one batch of SCRH.  
Figure 7, Efflux of CDCA and its conjugates by day-4 SCRH:  Sinusoidal [in standard buffer 
(o)] or combined ‘sinusoidal + canalicular’ [in Ca++/Mg++-free buffer (□)] efflux of CDCA and 
GCDCA by day-4 SCRH seeded in 6-well culture plates. Following a 4 h exposure of day-4 
SCRH to 5-100 µM CDCA, hepatocytes were rinsed (to remove residual extracellular BA) and 
immediately incubated for 10 min with standard or Ca++/Mg++-free buffer. Data represents mean 
(± SD) amounts of CDCA or GCDCA measured in triplicate. 
Figure 8, Time-dependent accumulation of CDCA and its conjugates: Compositional bar 
charts for absolute amounts (nmol/cm2) of CDCA and its conjugates (GCDCA and TCDCA) in 
cells and bile networks of SCRH, after incubating day-1(A) or day-3 (B) SCRH with 5, 25, 50 
and 100 µM of CDCA for 30 min or 4 h, followed by incubations with standard buffer for 10 
min. Data represents mean values of triplicate measurements obtained from a single batch (30 
min) or three batches (4 h) of hepatocytes for each time point. 
 
 
